Dhanwantary Medicare & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 15-11-2024
- Paid Up Capital ₹ 1.52 M
as on 15-11-2024
- Company Age 24 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.81 Cr
as on 15-11-2024
- Satisfied Charges ₹ 5.06 Cr
as on 15-11-2024
- Revenue 3.29%
(FY 2023)
- Profit 157.63%
(FY 2023)
- Ebitda 284.90%
(FY 2023)
- Net Worth 1.97%
(FY 2023)
- Total Assets 16.41%
(FY 2023)
About Dhanwantary Medicare & Research Centre
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 1.52 M.
The company currently has active open charges totaling ₹4.81 Cr. The company has closed loans amounting to ₹5.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Khandelwal and Shashi Khandelwal serve as directors at the Company.
- CIN/LLPIN
U85100WB2000PTC091928
- Company No.
091928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Social Media
What products or services does Dhanwantary Medicare & Research Centre Private Limited offer?
Dhanwantary Medicare & Research Centre Private Limited offers a wide range of products and services, including Anti Cancer Medicines, Venclexta Anti Cancer Medicines, Pharmaceutical Medicine, Generic Medicines.
Who are the key members and board of directors at Dhanwantary Medicare & Research Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Khandelwal  | Director | 02-Jun-2000 | Current |
| Shashi Khandelwal | Director | 02-Jun-2000 | Current |
Financial Performance of Dhanwantary Medicare & Research Centre.
Dhanwantary Medicare & Research Centre Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.29% increase. The company also saw a substantial improvement in profitability, with a 157.63% increase in profit. The company's net worth moved up by a moderate rise of 1.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhanwantary Medicare & Research Centre?
In 2023, Dhanwantary Medicare & Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Nov 2022 | ₹0.60 M | Open |
Axis Bank Limited Creation Date: 02 Jan 2012 | ₹4.75 Cr | Open |
Hdfc Bank Limited Creation Date: 03 Mar 2010 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Dhanwantary Medicare & Research Centre?
Dhanwantary Medicare & Research Centre has a workforce of 86 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhanwantary Medicare & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanwantary Medicare & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
